Company Overview of Takeda California, Inc.
Takeda California, Inc. operates as a structure-based drug discovery company. The company integrates protein crystallography and drug discovery technologies to generate investigational new drug candidates for the treatment of metabolic diseases, cancer, and inflammation. It develops Alogliptin (SYR322), a potential treatment for type II diabetes. The company was formerly known as Takeda San Diego, Inc. and changed its name to Takeda California, Inc. in January 2012. The company was founded in 1999 and is based in San Diego, California. Takeda California, Inc. operates as a subsidiary of Takeda America Holdings, Inc.
10410 Science Center Drive
San Diego, CA 92121
Founded in 1999
Key Executives for Takeda California, Inc.
Takeda California, Inc. Key Developments
Similar Private Companies By Industry
|Ventrix, Inc.||United States|
|Zone Therapeutics, Inc.||United States|
|Millennium Predictive Medicine, Inc.||United States|
|Dynal Biotech LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- Miami Beach, FL | Recruit GaapPosted: May 22
- Riverside, CA | RecruitarrowPosted: May 22
- Warren, NJ | StarPoint SolutionsPosted: May 23
Sponsored Financial Commentaries
To contact Takeda California, Inc., please visit www.takedacalifornia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.